T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

This is the authors' abstract. We don't add key points for this paper.

The field of immunology has recently experienced enormous advances from which most have so far not been incorporated into standard medical practice (Davis, 2008). One approach to fully exploit the existing wealth of knowledge is to implement a systematic strategy to evaluate the immune system. The potential benefit of such an approach is that it may lead to results that can be translated into the rational development of diagnostics and therapeutics (Hoos et al., 2011). Two prerequisites for its application are that (1) applied immune assays lead to reproducible results (van der Burg et al., 2011), and (2) sets of experimental results will be reported and deposited in a way that supports maximum use of data (Janetzki et al., 2009; Sansone et al., 2012).